Are you actively looking to work with pharma and biotech companies developing personalised cancer therapeutics?
The NeoAg Series provides the only end-to-end industry dedicated forum focused on the challenges faced by pharma, biotech, and academia looking to advance neoantigen targeting immunotherapies.
Senior decision makers from pharmaceutical and biotech companies are actively seeking partners with reliable and scientifically robust solutions to support their research efforts.
Partnering with the Neoantigen Summit Europe will ensure you capitalise on the market share early, cement your position as an industry leader and support the growth in next-generation immunotherapies.
Showcase your expertise and educate the industry on how you can support and streamline their efforts.
Build new relationships via targeted networking with senior level decision makers from leading pharma and biotech organisations.
Drive your brand and cement your reputation to maximize exposure and differentiate yourself from competitors.